Status:
COMPLETED
Isoflavones for Promoting Calcium Absorption and Preventing Bone Loss in Post Menopausal Women
Lead Sponsor:
Purdue University
Collaborating Sponsors:
National Center for Complementary and Integrative Health (NCCIH)
Office of Dietary Supplements (ODS)
Conditions:
Osteoporosis
Osteopenia
Eligibility:
FEMALE
Phase:
PHASE1
Brief Summary
Estrogen is a hormone that helps prevent calcium loss and bone breakdown. During menopause, estrogen levels decrease. Insufficient amounts of estrogen may lead to bone loss and possibly osteoporosis. ...
Detailed Description
Estrogen is a hormone that activates bone-forming cells and prevents calcium loss and bone breakdown. During menopause, estrogen levels decrease. Insufficient amounts of estrogen may accelerate bone b...
Eligibility Criteria
Inclusion
- At least 4 years post-menopausal
Exclusion
- Not currently taking estrogen replacement therapy or undergoing any treatment for osteoporosis
- Diagnosis of breast cancer
- Results of mammogram suggesting breast cancer
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2010
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT00244907
Start Date
January 1 2006
End Date
May 1 2010
Last Update
May 4 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Purdue University
West Lafayette, Indiana, United States, 47907